2019

A multi-institutional team led by research faculty at Children’s National in Washington, D.C., finds that extracellular vesicles derived from kids’ fat can play a pivotal role in ratcheting up risk for atherosclerotic cardiovascular disease well before any worrisome symptoms become visible.

This year’s symposium will explore the pediatric device clinical trial process, including progress insights, current challenges and potential solutions.

Lower firearm-related deaths among children and adolescents in states with stricter firearm laws.

In late May 2019, Children’s National neonatal intensive care unit (NICU) introduced NicView^TM, a camera system that enables parents to log in from any internet-enabled device to see their infants virtually when they are unable to visit the NICU in person.

U.S. News & World Report ranked Children’s National #6 overall for its Best Children’s Hospitals annual rankings for 2019-20, with a #1 ranking in newborn care for the third straight year.

Children’s National Health System now offers the PLAT-05 trial for pediatric patients with relapsed positive acute lymphoblastic leukemia (ALL).

A 10-week pilot study at Children’s National integrated weekly caregiver coaching, personalized  glucose monitoring and incentives into standard treatment for 25 pediatric patients with type 1 diabetes, lowering A1c by .5%.

Children’s National and The HSC Health Care System have signed a definitive agreement to create an integrated partnership that will provide seamless care for children and young adults with complex medical needs.

A pre-clinical study at Children’s National Health System that investigates the use of nicotine-like, anti-inflammatory medications to reduce limb damage caused by the body’s inflammatory mechanisms has earned the Angela S.M. Kuo Memorial Award Research Grant.

Learn more about the winners of the NCC-PDI "Make Your Medical Device Pitch for Kids!" competition. Each winner will receive $50,000 in grant funding and access to an innovator accelerator program.